The R&D Blueprint is a global strategy and preparedness plan that allows the rapid activation of R&D activities during epidemic
The World Health Organization (WHO) declared a Public Health Emergency of International Concern in February 2016, based on the suspected link between Zika virus infection, congenital malformations, and neurologic syndromes. Since then, several developers and laboratories have developed Zika tests, but none that responds to all the characteristics that would make a real difference to the epidemic.
The World Health Organization (WHO) violated sound standards of medical care and human rights by nudging poorer countries to follow less expensive, untested and largely ineffective treatment protocols for tuberculosis patients, a new pape
Adults and children with HIV who start antiretroviral therapy (ART) as early as possible reduce their risk of developing serious HIV-related infections, according to new findings published in the journal Clinical Infectious Diseases on Ju
Emerging evidence suggests a broader range of possible complications for babies born to women affected with Zika virus. These could go beyond microcephaly to effects on other brain abnormalities. The World Health Organization (WHO) is coordinating efforts to understand the broader range of complications that define congenital Zika virus syndrome and invites partners to join in this effort.
The World Health Organization (WHO) has updated guidance originally published on Feb. 18, 2016 to provide advice on the prevention of sexual transmission of Zika virus.
The ninth meeting of the Emergency Committee under the International Health Regulations (2005) (IHR) regarding the international spread of poliovirus was convened via teleconference by the director-general on May 12, 2016.